Master of Research in Cardiac and Vascular Medicine

For the British Heart Foundation 4 year MRes/PhD (comprised of this 1 year full-time MRes in Cardiac & Vascular Medicine, leading to a 3 year PhD) please visit the findaphd web page for more information. Applicants apply using the application button here on the QMUL website but please indicate on your application form under the Funding section (page 6) that you are applying for funding under ‘WHRI/BHF’.

Do you want to be part of the UK biomedical translational agenda? Do you have the skills to take molecular concepts and apply them to in vivo studies? Are you interested in finding out why inflammation is at the root of society's contemporary disoders such as heart disease and cancer? Do you think you might like to do a PhD but lack all the necessary skills? If these are some of your thoughts about your future, then this is the programme for you.

This course provides state-of-the-art practical training in modern molecular and cellular pharmacological techniques alongside their application to in vivo methods of pharmacological investigation of cardiac and vascular inflammatory disease mechanisms. The programme will deliver scientists adept in the crucial skill set needed for successful careers in UK Life Sciences, especially deeper phenotyping in cardiac and vascular inflammation research (e.g. rheumatoid arthritis, atherosclerosis, pulmonary hypertension, hypertension, arrhythmia, nephrology or cancer).
In particular this course is designed to provide a springboard for those individuals wishing to a PhD in this field of research.

This programme will:
1. Give you state-of-the-art practical training in modern molecular and cellular pharmacological techniques, specialising in inflammation as it pertains to the heart and vasculature
2. Develop the skills you need to conduct cardiovascular biomedical research
3. Enable you to contribute to the research culture and knowledge base in healthcare
4. Provide a solid basis for further study.

Why study your MRes in Cardiac & Vascular Medicine at Queen Mary?

Barts and the London School of Medicine and Dentistry is comprised of two world renowned teaching hospitals, St Bartholomew’s and The Royal London, which have made, and continue to make, an outstanding contribution to modern medicine. In the latest Research Excellence Framework (REF 2014) Barts and The London School of Medicine and Dentistry was placed within the top seven UK institutions in all three Units of Assessment – Clinical Medicine; Public Health, Health Services and Primary Care; and Allied Health Professions, Dentistry, Nursing and Pharmacy.
The William Harvey Research Institute (WHRI), as part of the Medical School, comprises over 530 clinicians and scientists from 45 countries. It is one of Europe's largest multi-disciplinary pharmacological institutes, conducting world-leading research in the fields of cardiovascular, endocrine and inflammation science, and an international reputation for training talented scientists for success in 'translational' research. In 2014 REF, 90 per cent of research at the WHRI was rated as world leading or internationally excellent. It is upon these very strong foundations for translational research excellence that we offer this course. The WHRI embraces advances in the 'omic' specialties alongside an extremely strong portfolio of in vivo pharmacological research utilising cutting-edge in-vivo technologies (eg, live imaging/confocal/small animal PET-CT).